DaVita (DVA) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

DaVita NYSE: DVA expects a meaningful sequential decline in dialysis treatments in the fourth quarter because of calendar effects, but higher revenue per treatment should help offset the impact, Chief Financial Officer J…

LOS ANGELES--(BUSINESS WIRE)---- $DVA--DVA Investors Have Opportunity to Join DaVita Inc. Fraud Investigation with SBS Law.…

Washington Attorney General Nick Brown on Tuesday filed a lawsuit accusing the state's two largest for-profit dialysis providers of imposing illegal noncompete agreements on medical directors, blocking competition and re…

NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA). Such investors are advised to contact Danielle Peyton at newac…

DaVita Inc. (NYSE: DVA - Get Free Report) shares passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $179.73 and traded as high as $183.50. DaVita shares last tr…

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

DaVita Inc. (DVA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript…

DaVita NYSE: DVA expects stronger dialysis treatment growth and pharmaceutical cost savings to help offset reimbursement pressures in 2027, though Chief Financial Officer Joel Ackerman said changes in patients' insurance…

NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) for potentia…

DaVita Inc. (DVA) Presents at 2026 UBS Global Healthcare Conference Transcript…

NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA). Such investors are advised to contact Danielle Peyton at newact…

DaVita HealthCare (DVA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.…

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on DaVita Inc. ("DaVita" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conduct…

DENVER, Nov. 3, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its Chief Financial Officer, Joel Ackerman, and its Group Vice President of Investor Relations, Nic Eliason, will participate in fireside …

LOS ANGELES--(BUSINESS WIRE)--DaVita Inc. ("DaVita" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential secur…

DVA's Q3 earnings surge 52.2% as revenues rise 4.6%, fueled by strong kidney care and international growth despite rising costs and margin pressure.…

DaVita NYSE: DVA reported third-quarter adjusted operating income of $561 million, adjusted earnings per share of $3.82 and free cash flow of $276 million, while narrowing its full-year 2026 outlook. The kidney-care prov…

DaVita Inc. (DVA) Q3 2026 Earnings Call Transcript…

DaVita HealthCare (DVA) came out with quarterly earnings of $3.82 per share, beating the Zacks Consensus Estimate of $3.78 per share. This compares to earnings of $2.51 per share a year ago.…

DaVita (NYSE:DVA) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.…

DENVER, Oct. 29, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2026. Financial and operating highlights for the quarter ended September 30, 202…

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA). Such investors are advised to contact Danielle Peyton at newac…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 11. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.
Quiet tape today.

